RxSight, Inc.
RxSight, Inc.（RXST）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · RXST · 截至 2026年6月8日
活动摘要
买入笔数
6
P-Purchase only
卖出笔数
32
近12个月
买卖比
0.19
Buy/Sell (by trades)
整体情绪
RxSight, Inc.内部人在过去近12个月主要在卖出股份，卖出行为通常由预设的Rule 10b5-1计划驱动，不一定代表对公司的负面看法。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月8日
RXST 季度内部人买卖趋势
RXST 内幕交易卖出 · RXST 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 8, 2026
活跃内部人
近12个月交易最活跃 · RXST CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
RXST 高管卖出股份 · RXST 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Apr 17, 2026 | Goldshleger Ilya COO | Option | 12,489 | $52K | Form 4 |
| Feb 28, 2026 | Wilterding Mark CFO | Option | 20,441 | — | Form 4 |
| Feb 28, 2026 | Wilterding Mark CFO | Other | 8,068 | $61K | Form 4 |
| Feb 28, 2026 | Gaines Scott Chief Customer Officer | Option | 6,261 | — | Form 4 |
| Feb 28, 2026 | Gaines Scott Chief Customer Officer | Other | 2,580 | $20K | Form 4 |
| Sep 25, 2025 | Goldshleger Ilya See remarks | Option | 8,349 | $34K | Form 4 |
| Sep 25, 2025 | Goldshleger Ilya See remarks | Option | 15,096 | $66K | Form 4 |
| Jul 31, 2025 | COHEN RAYMOND W Director | Award | 35,668 | — | Form 4 |
| Jun 3, 2025 | LINK WILLIAM J PHD Director | Award | 10,752 | — | Form 4 |
| Jun 3, 2025 | Fountain Tamara Director | Award | 10,752 | — | Form 4 |
| Jun 3, 2025 | Warner Robert Keith Director | Award | 10,752 | — | Form 4 |
| Jun 3, 2025 | Maniar Shweta Director | Award | 10,752 | — | Form 4 |
| Jun 3, 2025 | PALMISANO ROBERT J Director | Award | 10,752 | — | Form 4 |
| Jun 3, 2025 | Andrews Julie Director | Award | 10,752 | — | Form 4 |
| Jun 3, 2025 | Tammenoms Bakker Juliet Director | Award | 10,752 | — | Form 4 |
| Jun 3, 2025 | Corley Jesse Anderson Director | Award | 10,752 | — | Form 4 |
| Jun 2, 2025 | Weinberg Eric See remarks | Option | 188,002 | $739K | Form 4 |
| Apr 14, 2025 | Thunen Shelley B See remarks | Option | 7,792 | $34K | Form 4 |
| Mar 12, 2025 | Fountain Tamara Director | Sale | 7,000 | $180K | Form 4 |
| Jan 22, 2025 | Maniar Shweta Director | Sale | 3,519 | $109K | Form 4 |
| Jan 16, 2025 | Corley Jesse Anderson Director | Purchase | 1,767 | $55K | Form 4 |
| Jan 15, 2025 | Corley Jesse Anderson Director | Purchase | 1,443 | $45K | Form 4 |
| Nov 29, 2024 | Goldshleger Ilya See remarks | Option | 3,105 | $47K | Form 4 |
| Nov 29, 2024 | Goldshleger Ilya See remarks | Sale | 3,105 | $143K | Form 4 |
| Nov 26, 2024 | Maniar Shweta Director | Sale | 3,782 | $174K | Form 4 |
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 RXST 内幕交易
RXST 内幕交易
RxSight, Inc.（RXST）内幕交易数据来源于公司内部人（包括Goldshleger Ilya (COO), Wilterding Mark (CFO), Gaines Scott (Chief Customer Officer)）提交的SEC Form 4申报文件。过去12个月内，4位内部人向SEC提交了交易申报。RXST内部人近期主要在卖出，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看RxSight, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
RXST 内幕交易 · 5个问题RxSight, Inc.（RXST）的内部人包括高管和董事，如Goldshleger Ilya (COO), Wilterding Mark (CFO), Gaines Scott (Chief Customer Officer)等。过去12个月内，4位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 8, 2026